id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-1997-D-0444-0038,FDA,FDA-1997-D-0444,"Special Considerations, Incentives, and Programs to Support the Approval of New Animal Drugs for Minor Uses and for Minor Species; Guidance for Industry; #61; Final Guidance",Other,Guidance,2023-12-22T05:00:00Z,2023,12,2023-12-22T05:00:00Z,,2024-11-12T06:22:09Z,,1,0,090000648634c336
FDA-1997-D-0444-0037,FDA,FDA-1997-D-0444,"Special Considerations, Incentives, and Programs To Support the Approval of New Animal Drugs for Minor Uses and for Minor Species; Guidance for Industry; Availability",Notice,Notice of Availability,2023-12-22T05:00:00Z,2023,12,,,2023-12-22T15:18:01Z,2023-28287,0,0,090000648635114c